Inventor · disambiguated record
Christopher Richard Parish
Also filed as: PARISH CHRISTOPHER · PARISH CHRISTOPHER R · PARISH CHRISTOPHER RICHARD
21 granted patents·15 pending applications·432 citations·filing 1992–2023
95Inventor score
Files withUNIV AUSTRALIAN16LIPOTEK PTY LTD6ALTIN JOSEPH4UNIV AUSTRALIAN NATIONAL3PARISH CHRISTOPHER RICHARD2
Top patents by PatentIndex Score
36 records- 0192US5677181AAngiogenesis inhibitory antibodiesUNIV AUSTRALIAN·Filed 1993·Granted Oct 14, 1997·111 cites·9 claims
- 0288US5874081ATherapeutic compositions and methods for inhibition and treatment of tumor associated angiogenesisUNIV AUSTRALIAN·Filed 1997·Granted Feb 23, 1999·59 cites·13 claims
- 0386US6143730APreparation and use of sulfated oligosaccharidesUNIV AUSTRALIAN·Filed 1996·Granted Nov 7, 2000·76 cites·25 claims
- 0477US6352852B1Method for the purification of human platelet heparanaseUNIV AUSTRALIAN·Filed 2000·Granted Mar 5, 2002·4 cites·6 claims
- 0576US9226939B2Histone inhibitionSTEPHENS ROSS WENTWORTH·Filed 2011·Granted Jan 5, 2016·4 cites·12 claims
- 0669US5541166ASulphated polysaccharides having anti-metastatic and/or anti-inflammatory activityUNIV AUSTRALIAN·Filed 1992·Granted Jul 30, 1996·45 cites·4 claims
- 0768US12295966B2Compounds for treating and preventing extracellular histone mediated pathologiesUNIV AUSTRALIAN NATIONAL·Filed 2023·Granted May 13, 2025·0 cites·12 claims
- 0866US8779107B2Composition for targeting dendritic cellsALTIN JOSEPH·Filed 2009·Granted Jul 15, 2014·1 cites·17 claims
- 0966US6242238B1Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses thereforUNIV AUSTRALIAN·Filed 1998·Granted Jun 5, 2001·27 cites·36 claims
- 1064US6271215B1Sulfated oligosaccharides having anticoagulant/antithrombotic activityUNIV AUSTRALIAN·Filed 1998·Granted Aug 7, 2001·21 cites·19 claims
- 1161US5976782AIn-vitro angiogenesis assayUNIV AUSTRALIAN·Filed 1995·Granted Nov 2, 1999·26 cites·45 claims
- 1258US2008233143A1Adjuvanting MaterialLIPOTEK PTY LTD·Filed 2006·Application pending·0 cites
- 1356US11628179B2Compounds for treating and preventing extracellular histone mediated pathologiesUNIV AUSTRALIAN NATIONAL·Filed 2018·Granted Apr 18, 2023·0 cites·11 claims
- 1455US2014079728A1Adjuvanting materialLIPOTEK PTY LTD·Filed 2013·Application pending·0 cites
- 1552US5691346ACastanospermine as an anti-inflammatory and immunosuppressant agentUNIV AUSTRALIAN·Filed 1993·Granted Nov 25, 1997·17 cites·8 claims
- 1652US2015307545A1Adjuvanting materialLIPOTEK PTY LTD·Filed 2015·Application pending·0 cites
- 1751US6638916B1Use of sulfated oligosaccharides as inhibitors of cardiovascular diseaseUNIV AUSTRALIAN·Filed 1998·Granted Oct 28, 2003·10 cites·5 claims
- 1849US2011200632A1Adjuvanting materialLIPOTEK PTY LTD·Filed 2011·Application pending·0 cites
- 1948US6207402B1Detection of mammalian heparanase activity and purification of mammalian heparanaseAUSTRALIAN NAT UNIVERSITY ACT·Filed 1997·Granted Mar 27, 2001·11 cites·22 claims
- 2048US2011104173A1Inhibition of degradation of extracellular matrixUNIV AUSTRALIAN·Filed 2007·Application pending·0 cites
- 2147US2003082654A1Novel cancer marker and uses therefor in the diagnosis of cancerFiled 2002·Application pending·0 cites
- 2247US2005003358A1Novel cancer marker and uses therefor in the diagnosis of cancerFiled 2002·Application pending·0 cites
- 2346US2010143456A1Model membrane systemsALTIN JOSEPH·Filed 2009·Application pending·0 cites
- 2445US2008038281A1Model membrane systemsUNIV AUSTRALIAN·Filed 2007·Application pending·0 cites
- 2544US12239650B2Compounds for treating and preventing net associated complicationsUNIV AUSTRALIAN NATIONAL·Filed 2019·Granted Mar 4, 2025·0 cites·6 claims
- 2644US5837709AUse of castanospermine as an anti-inflammatory and immunosupressant agentUNIV AUSTRALIAN·Filed 1995·Granted Nov 17, 1998·9 cites·14 claims
- 2744US5506210APhosphosugar-based anti-inflammatory and/or immunosuppressive drugsUNIV AUSTRALIAN·Filed 1992·Granted Apr 9, 1996·11 cites·17 claims
- 2841US2014341971A1Composition for targeting dendritic cellsALTIN JOSEPH·Filed 2014·Application pending·0 cites
- 2941US2004029194A1Method of identifying cancer markers and uses therefor in the diagnosis of cancerFiled 2001·Application pending·0 cites
- 3039US2009209485A1Modulating angiogenesis with nod factors such as glucosamine oligosaccharidesPARISH CHRISTOPHER RICHARD·Filed 2006·Application pending·0 cites
- 3138US2007026057A1In vivo targeting of dendritic cellsLIPOTEK PTY LTD·Filed 2004·Application pending·0 cites
- 3237US2013143840A1Heparan sulfate replacement therapyPARISH CHRISTOPHER RICHARD·Filed 2011·Application pending·0 cites
- 3336US10507236B2Chimeric proteinsLIPOTEK PTY LTD·Filed 2015·Granted Dec 17, 2019·0 cites·13 claims
- 3436US7173019B2Linked cyclitols and their polysulfated derivativesUNIV AUSTRALIAN·Filed 2002·Granted Feb 6, 2007·0 cites·21 claims
- 3535US2013142864A1In vivo targeting of dendritic cellsALTIN JOSEPH·Filed 2012·Application pending·0 cites
- 3630US6670339B1Use of sulfated oligosaccharides in lowering blood triglyceride levelsUNIV AUSTRALIAN·Filed 1998·Granted Dec 30, 2003·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Richard Parish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →